Latest News

Tips, contraindications for superficial chemical peels reviewed


 

AT THE MEDSCAPE LIVE! PIGMENTARY DISORDERS SYMPOSIUM

Know your comfort zone

Conference chair Pearl Grimes, MD, director of The Vitiligo & Pigmentation Institute of Southern California in Los Angeles, said superficial peels are best for dermatologists new to peeling until they gain comfort with experience.

Superficial and medium-depth peels work well for mild to moderate photoaging, she said at the meeting.

“We know that in darker skin we have more intrinsic aging rather than photoaging. We have more textural changes, hyperpigmentation,” Dr. Grimes said.

For Fitzpatrick skin types I-III, she said, “you can do superficial, medium, and deep peels.” For darker skin types, “I typically stay in the superficial, medium range.”

She said that she uses retinoids to exfoliate before a superficial peel but added, “you’ve got to stop them early because retinoids can make a superficial peel a medium-depth peel.”

Taking photos is important before any procedure, she said, as is spending time with patients clarifying their outcome expectations.

“I love peeling,” Dr. Grimes said. “And it’s cost effective. If you don’t want to spend a ton of money, it’s amazing what you can achieve with chemical peeling.”

When asked by a member of the audience whether they avoid superficial peels in women who are pregnant or breastfeeding, both Dr. Woolery-Lloyd and Dr. Grimes said they do avoid them in those patients.

Dr. Grimes said she tells her patients, especially in the first trimester, “I am the most conservative woman on the planet. I do nothing during the first trimester.”

Dr. Woolery-Lloyd has been a speaker for Ortho Dermatologics, Loreal and EPI, and has done research for Pfizer, Galderma, Allergan, Arcutis, Vyne, Merz, and Eirion. She has been on advisory boards for Loreal, Allergan, Ortho Dermatologics, Pfize,r and Merz. Dr. Grimes reports grant/research Support from Clinuvel Pharmaceuticals, Incyte, Johnson & Johnson, LASEROPTEK, L’Oréal USA, Pfizer, Procter & Gamble, skinbetter science, and Versicolor Technologies, and is on the speakers bureau/receives honoraria for non-CME for Incyte and Procter & Gamble; and is a consultant or is on the advisory board for L’Oréal USA and Procter & Gamble. She has stock options in Versicolor Technologies.

Pages

Recommended Reading

FDA cautions against using OTC products to remove skin spots, moles
Clinician Reviews
FDA approves topical ruxolitinib for nonsegmental vitiligo
Clinician Reviews
Pigmented Papules on the Face, Neck, and Chest
Clinician Reviews
Dermatologists share vitiligo breakthrough news with patients
Clinician Reviews
VTE risk not elevated in AD patients on JAK inhibitors: Study
Clinician Reviews
Linear Hypopigmentation on the Right Arm
Clinician Reviews
Ruxolitinib repigments many vitiligo-affected body areas
Clinician Reviews
Lego introduces first character with vitiligo
Clinician Reviews
New treatments aim to tame vitiligo
Clinician Reviews
SPF is only the start when recommending sunscreens
Clinician Reviews